Page last updated: 2024-09-05

sb 216763 and Astrocytosis

sb 216763 has been researched along with Astrocytosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beech, BH; Beech, WK; Begum, AN; Chen, P; Cole, GM; Davies, P; Frautschy, SA; Hu, S; Jones, MR; Kim, PC; Ma, Q; Oh, MS; Ubeda, OJ; Yang, F	1

Other Studies

1 other study(ies) available for sb 216763 and Astrocytosis

Article	Year
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiology of disease, 2009, Volume: 33, Issue:2 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caspase 3; Cells, Cultured; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Gliosis; Glycogen; Glycogen Synthase Kinase 3; Hippocampus; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Maze Learning; Nerve Degeneration; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins	2009

Article

Year

GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals.

Neurobiology of disease, 2009, Volume: 33, Issue:2

Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caspase 3; Cells, Cultured; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Gliosis; Glycogen; Glycogen Synthase Kinase 3; Hippocampus; Indoles; JNK Mitogen-Activated Protein Kinases; Maleimides; Maze Learning; Nerve Degeneration; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins

2009